You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Overview of Liver function in outpatient using cholesterol reducing drug Rosuvastatin
- In: Posters
- At: Amsterdam (the Netherlands) (2012)
- Type: Poster
- Poster code: HPS-P-019
- By: CHEN, Yu-Yu (Taipei, China Taiwan)
- Co-author(s): Huang, C.M. (, Taipei, China Taiwan)
Chang, H. (Cheng Hsing General Hospital, Taipei, China Taiwan) - Abstract:
? Background information: HMG-CoA is a reductase inhibitor (also known as the statin class) which effectively reduces LDL-C Drug ; rosuvastatin sees the largest use and has the strongest effect of these types of drugs.? Aims? Retrospective analysis will be conducted in clinical cases of monitoring liver function in hospital use of Rosuvastatin?
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026